More than 1 in 8 American adults are using GLP-1’s for weight loss. Experts say these are the nutritional gaps and side effects that should not to be overlooked. As GLP-1 medications continue to ...

The proliferation of GLP-1 use for weight loss and management of a variety of health conditions has made some restaurants fearful of traffic declines. But chains have yet to see any significant harm ...

A sizable percentage of people using Novo (NVO) and Lilly’s (LLY) GLP-1 drugs may be able to sustain their weight loss effects even months after discontinuing the popular obesity drugs, Reuters ...

X is putting its money where its mouth is. The Elon Musk-owned social media platform just pledged it will give $1 million to the user who creates the most popular long-form post using its newly ...

Long-term GLP-1 use slows medical cost growth, according to findings published Jan. 13 from professional services firm Aon. The firm analyzed 192,000 GLP-1 users from July 2022 to March 2025, ...

ABUJA, Dec 30 (Reuters) - Nigeria will enforce sweeping new tax laws from January 1, President Bola Tinubu said on Tuesday, dismissing criticism over discrepancies between the gazetted text and the ...

(RTTNews) - Adicet Bio (ACET) said its board has approved a one-for-16 reverse stock split of the company's common stock as part of efforts to regain compliance with Nasdaq's minimum bid price ...

Beginning Jan. 1, 2026, in accordance with Ordinance 5759 adopted by the Maui County Council, the County of Maui Department of Water Supply (DWS) will implement a new method for projecting water ...

Obesity is a well-known risk factor for breast cancer development and recurrence, and glucagon-like peptide 1 (GLP-1) receptor agonists have emerged as effective treatments for weight management. At ...

The world’s first GLP-1 weight loss treatment is being administered for pets on an experimental basis. The first cat was successfully dosed in the MEOW-1 study of OKV-119 – an investigational ...

CLEVELAND, Ohio — One in eight adults in the United States are now using Ozempic, Wegovy or similar GLP-1 drugs, according to a new KFF Health Tracking Poll. The poll also found that cost and side ...